Purification and quantification of opioid peptides in bone and joint tissues––a methodological study in the rat
The occurrence of methionine-enkephalin-Arg 6-Phe 7 (MEAP) and dynorphin B (DYNB) representing two main precursors of opioids was analyzed in specimens from rat cortical bone, periosteum, bone marrow and joint tissue by radioimmunoassay (RIA). MEAP and DYNB were extracted in a solution of 4% EDTA in...
Saved in:
Published in | Journal of orthopaedic research Vol. 21; no. 3; pp. 465 - 469 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Elsevier Ltd
01.05.2003
Wiley Subscription Services, Inc., A Wiley Company Blackwell Publishing Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The occurrence of methionine-enkephalin-Arg
6-Phe
7 (MEAP) and dynorphin B (DYNB) representing two main precursors of opioids was analyzed in specimens from rat cortical bone, periosteum, bone marrow and joint tissue by radioimmunoassay (RIA). MEAP and DYNB were extracted in a solution of 4% EDTA in 2 M acetic acid previously proven suitable for extraction of sensory and autonomic neuropeptides in bone and joints. In crude extracts of cortical bone, the immunoreactive (ir) levels of both opioids were under the detection limit of RIA. As for DYNB this also applied to crude extracts of joints and periosteum. Therefore, two purification methods were tested and compared, i.e. reverse phase C 18 and ion exchange chromatography. RIA of the elution fraction disclosed a significant difference between the two methods in terms of recovery, i.e. <5% and 50%, respectively. Thus, purification by ion exchange chromatography prior to RIA appeared to be the most suitable by providing measurable levels of both MEAP and DYNB in all tissues analyzed (highest in bone marrow, lowest in cortical bone). The described method offers a means of quantifying opioid peptides in bone and joints, which may be utilized in the analysis of regulatory mechanisms of nociception, growth and immune responses in different conditions. |
---|---|
Bibliography: | The Karolinska Institute Funds Swedish Medical Research Council - No. K98-04X-12588-01A; No. K97-12X-08652-09B ArticleID:JOR1100210313 The Salus Foundation The Swedish Alcohol Research Foundation ark:/67375/WNG-MN5DNNHX-Z istex:F6B0BF7B03378137F7FDCD06E3160E5E2FFFD760 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0736-0266 1554-527X 1554-527X |
DOI: | 10.1016/S0736-0266(02)00162-6 |